S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
S&P 500   3,819.72 (-1.31%)
DOW   31,270.09 (-0.39%)
QQQ   309.16 (-2.90%)
AAPL   122.06 (-2.45%)
MSFT   227.56 (-2.70%)
FB   255.41 (-1.39%)
GOOGL   2,011.41 (-2.57%)
TSLA   653.20 (-4.84%)
AMZN   3,005.00 (-2.89%)
NVDA   512.19 (-4.49%)
BABA   236.27 (+0.79%)
CGC   33.24 (-5.70%)
GE   13.44 (+3.54%)
MU   89.11 (-2.17%)
NIO   41.53 (-4.07%)
AMD   80.86 (-3.89%)
T   28.72 (+1.77%)
F   12.17 (-3.03%)
ACB   10.46 (-5.17%)
DIS   192.26 (-0.87%)
BA   228.56 (+2.43%)
NFLX   520.70 (-4.95%)
PFE   34.39 (+2.63%)
Log in
NASDAQ:GBSN

(GBSN) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.11
0.00 (0.00 %)
(As of 03/6/2018)
Add
Today's Range
$0.10
Now: $0.11▼
$0.12
50-Day Range N/A
52-Week Range
$0.03
Now: $0.11▼
$18.00
Volume104,097 shs
Average Volume99,205 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.
(GBSN) logo

Headlines

Op-Ed: One of America’s great wildernesses is being destroyed, bit by bit, in a silent massacre
November 29, 2020 |  latimes.com
‘SBI No $1B Adani loan’ ⁠— a screaming sign interrupts India vs Australia first ODI at Sydney
November 27, 2020 |  msn.com
WPX Energy's (WPX) CEO Rick Muncrief on Q3 2020 Results - Earnings Call Transcript
November 3, 2020 |  seekingalpha.com
How the Oklahoma ice storm helped strengthen Hurricane Zeta beyond expectations
October 30, 2020 |  msn.com
Africa’s year of zero: a special report on the future of wildlife tourism
October 28, 2020 |  ft.com
California sees new wildfires break out as powerful 100-plus mph winds buffet state
October 26, 2020 |  msn.com
Witnessing Peru’s Enduring, if Altered, Snow Star Festival
October 26, 2020 |  nytimes.com
California faces highest fire risk of 2020 with 70-plus mph winds, record dry conditions
October 25, 2020 |  msn.com
California’s devastating wildfire season may get even worse this weekend
October 24, 2020 |  msn.com
October Cold Snap Will Smash Records in Parts of U.S. Into Next Week | The Weather Channel
October 23, 2020 |  msn.com
California’s devastating wildfire season may get a lot worse this weekend
October 23, 2020 |  msn.com
Measuring the economic impact of declining water levels in Great Lakes Basin
October 1, 2020 |  msn.com
Sardar Sarovar Dam’s sudden water release flooded parts of Gujarat, suggests analysis
September 29, 2020 |  msn.com
How Old Is the Greenland Shark? The Answer Is Slippery
September 11, 2020 |  wsj.com
Monitor glacial lakes
September 8, 2020 |  msn.com
Big problems for smallest Great Lake: More precipitation, warmer temperatures and regulation plan upend life along Lake Ontario
September 3, 2020 |  msn.com
California’s Climate Tinderbox: A Scientist Explains the Fire Crisis
August 25, 2020 |  msn.com
Ancient Mars may have had storms that lasted thousands of years
August 21, 2020 |  msn.com
What's behind Trump's bizarre suggestion
August 2, 2020 |  www.msn.com
Standard Uranium Confirms Plans for Upcoming 5,000m Drill Program at its Flagship Davidson River Project
July 23, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:GBSN
Previous Symbol
CUSIPN/A
CIK1512138
Webgbscience.com
Phone+1-801-9901055
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank™

Overall MarketRank™

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Receive GBSN News and Ratings via Email

Sign-up to receive the latest news and ratings for GBSN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











(GBSN) (NASDAQ:GBSN) Frequently Asked Questions

What stocks does MarketBeat like better than (GBSN)?

Wall Street analysts have given (GBSN) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but (GBSN) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were (GBSN)'s earnings last quarter?

(GBSN) (NASDAQ:GBSN) released its earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share for the quarter. The medical research company earned $0.85 million during the quarter.
View (GBSN)'s earnings history.

When did (GBSN)'s stock split? How did (GBSN)'s stock split work?

(GBSN)'s stock reverse split before market open on Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 15th 2016. An investor that had 100 shares of (GBSN) stock prior to the reverse split would have 1 shares after the split.

Who are (GBSN)'s key executives?

(GBSN)'s management team includes the following people:
  • David Spafford, Executive Chairman of the Board (Age 55)
  • Robert Jenison, Senior Vice President - Research, Chief Technology Officer (Age 50)
  • Ryan Ashton, President, Chief Executive Officer, Director (Age 56)
  • Kirk K. Calhoun, Independent Director (Age 73)
  • Sam Chawla, Independent Director (Age 41)
  • Ronald K. Labrum, Independent Director (Age 60)

What other stocks do shareholders of (GBSN) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (GBSN) investors own include Macrocure Ltd. - Ordinary Share (MCUR), (LNCOQ) (LNCOQ), California Resources (CRC), (BBEPQ) (BBEPQ), (UPLMQ) (UPLMQ), VelocityShares Daily 2x VIX Short-Term ETN (TVIX), U.S. Energy (USEG), Synergy Pharmaceuticals (SGYP), BioCryst Pharmaceuticals (BCRX) and (LINEQ) (LINEQ).

What is (GBSN)'s stock symbol?

(GBSN) trades on the NASDAQ under the ticker symbol "GBSN."

What is (GBSN)'s stock price today?

One share of GBSN stock can currently be purchased for approximately $0.11.

What is (GBSN)'s official website?

The official website for (GBSN) is gbscience.com.

Where are (GBSN)'s headquarters?

(GBSN) is headquartered at 420 E South Temple Ste 520, SALT LAKE CITY, UT 84111-1362, United States.

How can I contact (GBSN)?

(GBSN)'s mailing address is 420 E South Temple Ste 520, SALT LAKE CITY, UT 84111-1362, United States. The medical research company can be reached via phone at +1-801-9901055.


This page was last updated on 3/3/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.